Food & Ag Economic Impact Panel Added to CEO & Investor Conference
WASHINGTON, D.C. (January 31, 2006) – Graham Brookes will be the expert speaker for the first agricultural biotechnology focus session to be included in the Biotechnology Industry Organization’s (BIO) CEO & Investor Conference in its eight-year history.
The conference, to be held February 14 and 15 in New York City, is designed to educate new investors and media on the value, risks and rewards offered by the industry and to fuel continued industry growth and investments in 2006. It will take place at the Waldorf=Astoria. Complimentary registration is open to qualified investors and members of the media at http://www.ceo.bio.org .
Brookes is a U.K.-based agricultural economist who specializes in examining the impact of policy, trade agreements and technology change on agricultural and related sectors. He is the author of “GM Crops: The Global Economic and Environmental Impact - The First Nine Years 1996-2004,” and has been analyzing the impact of policy and technology change, with special reference to European agriculture for the last 20 years.
The agricultural focus session, “Agricultural Biotechnology: Early innings in a new game changing the face of agriculture,” will be held from 9 a.m. to 10:25 a.m. on Tuesday, Feb. 14. Following Graham’s talk, representatives of small, medium and large biotech companies will each provide their perspective on where the industry has come from, and where it’s headed.
Kevin McCarthy, moderator, Banc of America Securities LLC
Hugh Grant, Monsanto Company
Dr. Richard Hamilton, Ceres Inc.
Andrew Baum, SemBioSys Genetics Inc.
Conference sponsors include Arent Fox LLP, AstraZeneca, Bank of America, Biogen Idec Inc., Dorsey & Whitney LLP, Ernst & Young LLP, Ferghana Partners Group, Heller Ehrman White & McAuliffe LLP, HSBC, Jefferies & Company, Inc., Johnson & Johnson, Knight Capital Group, Inc., Latham & Watkins LLP, Lazard, Merck & Co. Inc., Monsanto Company, Novartis, Novo Nordisk, Pfizer Inc., PricewaterhouseCoopers LLP, RBC Financial Group, Rodman & Renshaw, LLC, Stanford Group Company and VWR International
For more information about BIO CEO & Investor Conference 2006 or to register on-line, please visit http://www.ceo.bio.org .
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.
###